What they do
Iktos specializes in generative artificial intelligence applied to chemical research. The company offers software for synthetic planning and automated molecule design, enabling medicinal chemists to discover novel clinical candidates more efficiently.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- AI drug discovery
- Product type
- Platform software
- Stage
- Series A
- Headquarters
- Paris, France
- Region
- Europe
- Founded
- 2016
- Total funding
- $16M raised
Notable investors: Omnes Capital, M Ventures, Debiopharm Innovation Fund.